Quidel (NASDAQ:QDEL) has received 510(k) clearance from the FDA to market the Quidel Triage TOX Drug Screen, 94600, a fluorescence immunoassay for the qualitative determination of the presence of drug and/or metabolites in human urine of up to 9 drug assays.
The test is to be used with Quidel’s Triage MeterPro instrumented system.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.